Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
HIVAC-1e
gp160 Vaccine (MicroGeneSys)
Locations
2
United States
Vanderbilt Univ. Hosp. AVEG
Nashville, Tennessee, United States
UW - Seattle AVEG
Seattle, Washington, United States
Completion Date
December 1, 1992
Last Updated
October 27, 2021
NCT06694805
NCT04142047
NCT05398185
NCT07428330
NCT07225530
NCT05897099
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions